RxDoctor Payments DataLook up a doctor →

Douglas Conaway, MD

Rheumatology · Myrtle Beach, SCNPI 1316944499

Payments from drug & device makers

$507,404in general payments, 2019–2025

Across 1,642 payments — averaging $309.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$301K
  • Janssen Scientific Affairs, LLC$91K
  • Johnson & Johnson$63K
  • Pfizer$27K
  • Janssen Research & Development, LLC$9K
  • AbbVie$7K
  • plus $10K from 34 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)648$301,114
Janssen Scientific Affairs, LLC94$90,650
Johnson & Johnson(2 entities)304$62,704
Pfizer69$27,446
Janssen Research & Development, LLC20$8,592
AbbVie226$7,316
GSK16$4,015
UCB, Inc.78$1,535
Novartis37$780
Genentech USA, Inc.22$420
AstraZeneca(2 entities)9$371
E.r. Squibb & Sons, L.L.C.19$306
Abbott11$230
Antares Pharma, Inc.10$229
Novo Nordisk9$202
Sanofi2$178
Bristol Myers Squibb9$172
Radius Health, Inc.9$129
BETA Bionics, Inc.4$125
Regeneron Healthcare Solutions, Inc.2$102
Mallinckrodt Hospital Products Inc.6$96
Lilly USA, LLC6$94
Boehringer Ingelheim5$90
Averitas Pharma Inc.2$59
Bayer3$55
Astellas Pharma US Inc3$51
Ultragenyx Pharmaceutical Inc.2$47
Madrigal Pharmaceuticals1$44
Aurinia Pharma U.S., Inc.2$37
Boston Scientific2$36
Dexcom, Inc.2$29
Insulet Corporation2$27
Otsuka America Pharmaceutical, Inc.1$22
Vital Connect, Inc1$22
Daiichi Sankyo Inc.1$17
Merck1$15
Eisai Inc.1$15
Takeda Pharmaceuticals U.S.A., Inc.1$13
Amarin Pharma, Inc.1$12
Shire North American Group Inc1$11

How this compares

$507,404 in reported general payments places this provider in the 90th percentile of 123 rheumatology providers in South Carolina.

See all rheumatology providers in South Carolina →

Medicare billing

Part B allowed, 2024
$1,323,859
Medicare patients
306
Services billed
75,639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other rheumatology in Myrtle Beach

See the full list for South Carolina →

Where these figures come from

Is this you, or does something look wrong? →